RFMK News .003
Rapid Fire Marketing Updates CANNAcig; Funds Sales and Distribution Office in Los Angeles; Online Store Now Open
2012-05-23 09:15 ET - News Release
CARSON CITY, Nev. and LOS ANGELES , May 23, 2012 /PRNewswire/ -- Rapid Fire Marketing (Pink Sheets: RFMK) announced today that the first round of Vapor Inhaler CANNAcig models have sold out at both Otherside Health Management, and our retail outlet, Tabu Smoke Shop. All the devices released worked as expected with very minimal returns. All of these returns were due completely to customer negligence. Of these few returned units, some were repaired on site and sent home with the customers without any further problems. Those units that were beyond repair were replaced, instructions for use reiterated, and those customers made no further returns thereafter. Both Tabu Smoke Shop and Otherside Health Management are excited with the success and happiness of their customers and eagerly await the next order with anticipation. These outlets, along with many other new retail location partnerships to be announced soon, will be fully stocked once the next shipment arrives.
Additionally, Rapid Fire Marketing has funded the sales and distribution office that is now set up and operational in Los Angeles, CA. Sales, distribution, customer service, repair, returns and accessory sales, as well as storage of back stock, will be conducted in this office. The office is now staffed and operational. The Company will fund and set up a comprehensive sales and accounting system by July 2012 as well. This system will track inventory, distributors, individual orders, replacement parts and accessories for products, provide for payment and billing services as well as many other functions. Because the system is accessed securely online, there will be no need to have a large office space with associated costs.
A complete sample package of the new and revised version of the Vapor Inhaler's CANNAcig model has arrived in Los Angeles, CA. While the first round production of the Vapor Inhaler's CANNAcig model was a big success, improvements were made before the second round of production could began. The revisions to the Vapor Inhaler's CANNAcig model from the first round of production are significant from appearance and the user experience standpoint that physical proof, and not just a photo proof, was requested before the remainder of the production occurred. The sample has been approved and production of the Vapor Inhaler's CANNAcig model is underway. They will be shipped once completed to our distribution center where orders will be completed and delivered.
